Announcements Trials
Browse Landscape

Phase

Phase NA 125Phase 2 119Phase 1 74Phase 3 30Phase 1/2 23Phase EARLY_PHASE1 9Phase 4 5Phase 2/3 1

Status

Completed 5Not yet recruiting 4Unknown 2Recruiting 2

Sponsor Class

OTHER 3OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 5Breast 1

Conditions

Breast Neoplasms 134Neoplasms 112Polycystic Ovary Syndrome 66Prostatic Neoplasms 63Colorectal Neoplasms 51Carcinoma, Non-Small-Cell Lung 46Pain 40Carcinoma, Hepatocellular 35Lung Neoplasms 34Keratosis, Actinic 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Neoplasm Metastasis 26Head and Neck Neoplasms 26Pain, Postoperative 25Stomach Neoplasms 24Colonic Neoplasms 23Multiple Myeloma 22Brain Neoplasms 21Pancreatic Neoplasms 20Lymphoma, Follicular 19Leukemia 19Anemia 19Uterine Cervical Neoplasms 18Leukemia, Myeloid, Acute 18Infertility 18Leiomyoma 17Lymphoma, Non-Hodgkin 16Lymphoma 16Cancer Pain 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15

Interventions

Medroxyprogesterone Acetate 2ferrous gluconate 1Metformin 1LY 353381 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × Completed × Endometrial Neoplasms × Clear all
NCT05651282 2026-04-13

RESToRE

University of British Columbia

Phase 4 Completed
96 enrolled
Gynecologic

Endometrial Neoplasms

NCT06049693 2024-03-29

IROGYN

National and Kapodistrian University of Athens

Phase 4 Completed
156 enrolled
Gynecologic

Endometrial Neoplasms

NCT03752606 2018-11-26

Application of Tachosil During Lymphadenectomy

Medical University of Lublin

Phase 4 Completed
50 enrolled
Gynecologic

Uterine Cervical Neoplasms, Lymphocele, Endometrial Neoplasms

NCT02872818 2016-08-23

Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia

Kayseri Education and Research Hospital

Phase 4 Completed
40 enrolled
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT00190697 2007-05-25

A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment

Eli Lilly and Company

Phase 4 Completed
70 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡